Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Recent studies using magnetic resonance spectroscopy have shown that decreased insulin-stimulated muscle glycogen synthesis due to a defect in insulin-stimulated glucose transport activity is a major factor in the pathogenesis of type 2 diabetes. The molecular mechanism underlying defective insulin-stimulated glucose transport activity can be attributed to increases in intramyocellular lipid metabolites such as fatty acyl CoAs and diacylglycerol, which in turn activate a serine/threonine kinase cascade, thus leading to defects in insulin signaling through Ser/Thr phosphorylation of insulin receptor substrate (IRS)-1. A similar mechanism is also observed in hepatic insulin resistance associated with nonalcoholic fatty liver, which is a common feature of type 2 diabetes, where increases in hepatocellular diacylglycerol content activate protein kinase C-ε, leading to reduced insulin-stimulated tyrosine phosphorylation of IRS-2. More recently, magnetic resonance spectroscopy studies in healthy lean elderly subjects and healthy lean insulin-resistant offspring of parents with type 2 diabetes have demonstrated that reduced mitochondrial function may predispose these individuals to intramyocellular lipid accumulation and insulin resistance. Further analysis has found that the reduction in mitochondrial function in the insulin-resistant offspring can be mostly attributed to reductions in mitochondrial density. By elucidating the cellular and molecular mechanisms responsible for insulin resistance, these studies provide potential new targets for the treatment and prevention of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DAGs have been reported to reduce insulin sensitivity in skeletal muscle (25).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [25]
In the citing paper
“These traits are most often observed in association with aging, severe obesity and type 2 diabetes but were also evident in young insulin-resistant offspring of parents with diabetes [60,62].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [60]
In the citing paper
“Recent studies have reported a mitochondrial defect in oxidative phosphorylation in skeletal muscle in variety of insulin resistant states.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [17]
In the citing paper
“suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [17]
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The World Health Organization estimates that by the year 2030, 366 million people will be afflicted with diabetes (1).”
BackgroundMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“Downstream molecules such as phosphatidylinositol-dependent kinase (PDK) and protein kinase B (PKB [AKT]) have a pleckstrin homology domain that enables these molecules to migrate toward the plasma membrane (28).”
BackgroundCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Using a similar approach, we used (31)P MRS to examine mitochondrial function in young lean insulin-resistant offspring of parents with type 2 diabetes (20).”
BackgroundMethodSelf-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Using (13)C/(31)P MRS, we directly assessed mitochondrial oxidative and phosphorylation activity in the healthy lean elderly volunteers with severe muscle insulin resistance and found that they have an 40% reduction in rates of oxidative phosphorylation activity associated with increased intramyocellular and intrahepa…”
MethodSelf-citation
Cited by
Items 201–300 of 872
Stanhope, K. L., Goran, M. I., Bosy‐Westphal, A., King, J. C., Schmidt, L. A., Schwarz, J. ‐., Stice, E., Sylvetsky, A. C., Turnbaugh, P. J., Bray, G. A., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12699 · Cited by 87
“promote hepatic insulin resistance (132) by increasing levels of diacylglycerol, which may activate novel protein kinase C and lead to serine phosphory-”
BackgroundGilbert, M. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13614 · Cited by 97
“ROLE OF TRIGLYCERIDE AND LIPID METABOLITES According to Morino et al.(10) and Ruderman et al.”
MethodKim, M. J., & Lim, Y. (2013) · Mediators of Inflammation · doi:10.1155/2013/510212 · Cited by 92
“In particular, PKC-βII, as one of the various isoforms of PKC, is well known to accelerate the pathogenesis of hyperglycemic kidney injuries, and it leads to insulin resistance as well as to dysfunction of various cells through the reduction of insulin receptor substrate- (IRS-) 2 tyrosine phosphorylation, resulting i…”
BackgroundNew insights into adipose tissue dysfunction in insulin resistance
Mlinar, B., & Marc, J. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.697 · Cited by 99
Lemecha, M., Morino, K., Imamura, T., Iwasaki, H., Ohashi, N., Ida, S., Sato, D., Sekine, O., Ugi, S., & Maegawa, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-33438-3 · Cited by 93
Self-citationThe Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
Swerdlow, R. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221286 · Cited by 93
Gastaldi, G., Russell, A. P., Golay, A., Giacobino, J., Habicht, F., Barthassat, V., Muzzin, P., & Bobbioni-Harsch, E. (2007) · Diabetologia · doi:10.1007/s00125-007-0782-1 · Cited by 90
“Skeletal muscle mitochondrial function is impaired in obese and in diabetic patients [1], and this may contribute to the development of insulin resistance [2].”
BackgroundAdipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans
Bilkovski, R., Schulte, D. M., Oberhauser, F., Mauer, J., Hampel, B., Gutschow, C. A., Krone, W., & Laudes, M. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.6 · Cited by 92
Pardo, R., Enguix, N., Lasheras, J., Feliu, J. E., Kralli, A., & Villena, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026989 · Cited by 86
“Type 2 diabetes is strongly associated with a decrease in mitochondrial mass and function [1].”
BackgroundLessard, S. J., Rivas, D. A., Alves-Wagner, A. B., Hirshman, M. F., Gallagher, I. J., Constantin-Teodosiu, D., Atkins, R., Greenhaff, P. L., Qi, N. R., Gustafsson, T., et al. (2013) · Diabetes · doi:10.2337/db13-0062 · Cited by 85
“Impaired mitochondrial capacity has been proposed as a mechanism contributing to the metabolic syndrome (30,31), and increased mitochondrial capacity contributes to improved aerobic exercise capacity with training (32).”
BackgroundYe, L., Varamini, B., Lamming, D. W., Sabatini, D. M., & Baur, J. A. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00177 · Cited by 79
“Moreover, evidence from human studies suggest that a 38% decrease in mitochondrial density may be enough to predispose humans to diabetes (Morino et al., 2006).”
BackgroundInfluentialTsutsumi, R., Yoshida, T., Nii, Y., Okahisa, N., Iwata, S., Tsukayama, M., Hashimoto, R., Taniguchi, Y., Sakaue, H., Hosaka, T., et al. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-32 · Cited by 87
“Skeletal muscle is one of the primary tissues responsible for insulin-stimulated glucose uptake, and reduced mitochondrial function plays an important role in the development of insulin resistance coupled with obesity [23,28].”
BackgroundMetabolic effects of obesity causing disease in childhood
Abrams, P., & Katz, L. E. L. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283424b37 · Cited by 93
Oxidative Stress, Intrauterine Growth Restriction, and Developmental Programming of Type 2 Diabetes
Rashid, C. S., Bansal, A., & Simmons, R. A. (2018) · Physiology · doi:10.1152/physiol.00023.2018 · Cited by 90
Mesarwi, O. A., Sharma, E. V., Jun, J. C., & Polotsky, V. Y. (2015) · Sleep and Biological Rhythms · doi:10.1111/sbr.12078 · Cited by 80
Lukjanenko, L., Brachat, S., Pierrel, E., Lach-Trifilieff, E., & Feige, J. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071084 · Cited by 82
Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Keim, N. L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1050 · Cited by 88
“We have suggested that the reductions of insulin sensitivity and glucose tolerance previously reported in the subjects from our study were primarily the result of fructose-induced increases of hepatic de novo lipogenesis leading to accumulation of hepatic lipid and subsequent diacylglycerol-mediated PKC activation (1,…”
BackgroundBrugnara, L., Vinaixa, M., Murillo, S., Samino, S., Rodriguez, M. A., Beltran, A., Lerín, C., Davison, G. W., Correig, X., & Novials, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040600 · Cited by 98
“Significant differences in mitochondrial number, structure and function have been described between insulin-resistant and insulin-sensitive subjects, but the causal link still remains unknown [46].”
BackgroundTriglyceride containing lipid droplets and lipid droplet-associated proteins
Olofsson, S., Boström, P., Andersson, L. K., Rutberg, M., Levin, M. C., Perman, J., & Borén, J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830dd09b · Cited by 93
McKenzie, H. C. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2010.12.008 · Cited by 84
“This accumulation disrupts the normal pathways that are responsible for insulin-induced glucose uptake in skeletal muscles and interferes with gluconeogenesis in the liver.(25) The result of all these interactions can be a fulminant self-perpetuating hyperlipidemia.”
BackgroundMitochondrial Dysfunction in Obesity and Reproduction
Das, M., Sauceda, C., & Webster, N. J. G. (2020) · Endocrinology · doi:10.1210/endocr/bqaa158 · Cited by 89
Stearoyl-CoA desaturase and insulin signaling — What is the molecular switch?
Dobrzyń, P., Jazurek, M., & Dobrzyń, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.007 · Cited by 89
Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes
Carpentier, A. C. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.10.009 · Cited by 104
“It has been shown that IR induced by experimental elevation f NEFA in human muscle is due to impaired glucose transport t the level of the plasma membrane [6].”
Impaired Mitochondrial Function and Insulin Resistance of Skeletal Muscle in Mitochondrial Diabetes
Szendroedi, J., Schmid, A. I., Meyerspeer, M., Cervin, C., Kacerovsky, M., Smekal, G., Gräser-Lang, S., Groop, L., & Roden, M. (2009) · Diabetes Care · doi:10.2337/dc08-2078 · Cited by 83
“Insulinresistant populations show reduced mitochondrial function and increased soleus muscle lipids (intramyocellular lipids [IMCLs]) and liver lipids (hepatocellular lipids [HCLs]) (1).”
BackgroundInsulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases
Sádaba, M. C., Martín‐Estal, I., Puche, J. E., & Castilla‐Cortázar, I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.03.010 · Cited by 88
Cappellari, G. G., Zanetti, M., Semolic, A., Vinci, P., Ruozi, G., Falcione, A., Filigheddu, N., Guarnieri, G., Graziani, A., Giacca, M., et al. (2016) · Diabetes · doi:10.2337/db15-1019 · Cited by 90
“Excess muscle ROS production and inflammation are indeed linked at the level of inhibitor of kB (IkB)/nuclear factor-kB (NF-kB) activation and may cause insulin resistance by inhibiting insulin signaling downstream of insulin receptor (2,3,5).”
BackgroundA Decreased Mitochondrial DNA Content Is Related to Insulin Resistance in Adolescents
Gianotti, T. F., Sookoian, S. C., Dieuzeide, G., García, S. I., Gemma, C., González, C. D., & Pirola, C. J. (2008) · Obesity · doi:10.1038/oby.2008.253 · Cited by 86
“Recent studies using magnetic resonance spectroscopy in skeletal muscle have shown that a reduction of the mitochondrial function in the insulin-resistant offspring of parents with type 2 diabetes can be mostly attributed to reductions in mitochondrial density (4).”
BackgroundResultChen, L.-L., Zhang, H.-H., Zheng, J., Hu, X., Kong, W., Hu, D., Wang, S.-X., & Zhang, P. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.002 · Cited by 81
“[5] Morino K, Petersen KF, Shulman GI.”
BackgroundSakurai, T., Iimuro, S., Araki, A., Umegaki, H., Ohashi, Y., Yokono, K., & Ito, H. (2009) · Gerontology · doi:10.1159/000246970 · Cited by 88
“It has also been reported that the prevalence of MetS increases with age [ ,”
BackgroundHCV and Oxidative Stress: Implications for HCV Life Cycle and HCV‐Associated Pathogenesis
Medvedev, R., Ploen, D., & Hildt, E. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9012580 · Cited by 90
“This results in reduced activation of downstream targets, that is, AKT and p38 [174, 175].”
BackgroundPraet, S. F. E., Jonkers, R. A. M., Schep, G., Stehouwer, C. D. A., Kuipers, H., Keizer, H. A., & van Loon, L. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0169 · Cited by 80
“Previous studies have shown that changes in muscle fibre-type composition (20‐23) ,m uscle oxidative capacity (MUOX) (24) and intramyocellular lipid (IMCL) (25, 26 ) and/or glycogen (25) content are associated with the development of skeletal muscle insulin resistance.”
BackgroundTXNIP Links Redox Circuitry to Glucose Control
Muoio, D. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.011 · Cited by 80
Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry
Miljkovic, I., Cauley, J. A., Petit, M. A., Ensrud, K. E., Strotmeyer, E., Sheu, Y., Gordon, C. L., Goodpaster, B. H., Bunker, C. H., Patrick, A. L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2541 · Cited by 79
Chen, W., Zhang, X., Birsoy, K., & Roeder, R. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005626107 · Cited by 79
“In relation to muscle-related disorders, it is important to note that whereas exercise stimulates a switch from fast to slower fibers (34), type II diabetes and obesity are often associated with a reduced slow and elevated fast fiber composition (35) and with mitochondrial dysfunction related to a lower mitochondrial…”
BackgroundYan, F., Li, N., Yue, Y., Wang, C., Zhao, L., Evivie, S. E., Li, B., & Huo, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02855 · Cited by 87
Malonyl CoenzymeA Decarboxylase Regulates Lipid and Glucose Metabolism in Human Skeletal Muscle
Bouzakri, K., Austin, R., Rune, A., Lassman, M. E., Garcia-Roves, P. M., Berger, J. P., Krook, A., Chibalin, A. V., Zhang, B. B., & Zierath, J. R. (2008) · Diabetes · doi:10.2337/db07-0583 · Cited by 77
“While the long-term effect of skeletal muscle MCD inhibition is unknown, chronic elevations in the local concentration of malonyl-CoA due to glucose infusion (44) or diabetes (13) are associated with peripheral and hepatic insulin resistance, due in part to an increase in diacylglycerol content and feedback inhibition…”
BackgroundMorino, K., Petersen, K. F., Sono, S., Choi, C. S., Samuel, V. T., Lin, A., Gallo, A., Zhao, H., Kashiwagi, A., Goldberg, I. J., et al. (2012) · Diabetes · doi:10.2337/db11-1391 · Cited by 77
Self-citationPranata, R., Huang, I., Irvan, I., Lim, M. A., & Vania, R. (2021) · Endocrine · doi:10.1007/s12020-021-02780-4 · Cited by 81
Zhang, Y., Wang, H., Zhang, L., Yuan, Y., & Yu, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.185 · Cited by 78
Foods for the prevention of diabetes: how do they work?
Thomas, T., & Pfeiffer, A. F. H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1229 · Cited by 73
“SFA-rich diets lead to an increase in intramyocellular lipid content, which is causally related to impaired insulin resistance [19,20], since specific lipid species (i.”
BackgroundPeng, Y., Liu, J., Shi, L., Tang, Y., Gao, D., Long, J., & Liu, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13563 · Cited by 75
“…to mitochondrial dysfunction (Takamura et al. 2012; Piya et al. 2013; Sylow et al. 2013) (Burkewitz et al. 2014; Sharma 2015), and its inactivation in peripheral tissues impairs insulin signaling (Petersen et al. 2003; Lowell and Shulman 2005; Morino et al. 2006; Kim et al. 2008; Liu et al. 2009).”
BackgroundKupriyanova, Y., Zaharia, O. P., Bobrov, P., Karusheva, Y., Burkart, V., Szendroedi, J., Hwang, J.-H., Roden, M., Roden, M., Al-Hasani, H., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.030 · Cited by 70
Snel, M., Gastaldelli, A., Ouwens, D. M., Hesselink, M. K. C., Schaart, G., Buzzigoli, E., Frölich, M., Romijn, J. A., Pijl, H., Meinders, A. E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3178 · Cited by 74
“Serine-phosphorylated insulin receptor substrate-1 is unable to activate PI3K and leads to disruption in the PI3K-PKB/AKT insulin signaling cascade (20).”
BackgroundPotential roles of vitamin E in age-related changes in skeletal muscle health
Chung, E., Mo, H., Wang, S. F., Zu, Y., Elfakhani, M., Rios, S. R., Chyu, M.-C., Yang, R., & Shen, C. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.09.005 · Cited by 79
Jazet, I., Schaart, G., Gastaldelli, A., Ferrannini, E., Hesselink, M., Schrauwen, P., Romijn, J., Maassen, J., Pijl, H., Ouwens, D., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0862-2 · Cited by 88
“It has been hypothesised that accumulation of IMCL metabolites is involved in the impaired insulin signalling via phosphorylation of IRS-1 and IRS-2 on serine residues, thereby rendering these serine-phosphorylated IRSs unable to associate with and activate PI3K [39].”
BackgroundInfluentialPhysiological and Molecular Determinants of Insulin Action in the Baboon
Chavez, A. O., Lopez-Alvarenga, J. C., Tejero, M. E., Triplitt, C., Bastarrachea, R. A., Sriwijitkamol, A., Tantiwong, P., Voruganti, V. S., Musi, N., Comuzzie, A. G., et al. (2008) · Diabetes · doi:10.2337/db07-0790 · Cited by 75
Su, Q., Baker, C., Christian, P., Naples, M., Tong, X., Zhang, K., Sántha, M., & Adeli, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00438.2013 · Cited by 80
“Mitochondrial dysfunction is a contributing factor to the onset of insulin resistance; impairment of mitochondrial function in human myocytes increases predisposition to intramyocellular lipid accumulation and insulin resistance (17, 28).”
Yamamoto, T., Habata, Y., Matsumoto, Y., Yasuhara, Y., Hashimoto, T., Hamajyo, H., Anayama, H., Fujii, R., Fuse, H., Shintani, Y., et al. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.05.004 · Cited by 79
“PGC-1α was determined to be a factor that increases the mitochondrial biogenesis of BAT under cold exposure [25] and is a key molecule that stimulates NRF1 transcription in conjunction with other transcriptional cofactors [26].”
BackgroundDeficiency of the Mitochondrial Electron Transport Chain in Muscle Does Not Cause Insulin Resistance
Han, D.-H., Hancock, C. R., Jung, S. R., Higashida, K., Kim, S. H., & Holloszy, J. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019739 · Cited by 71
“This finding led to the hypothesis that a reduction in mitochondrial content of skeletal muscle impairs the ability of muscle to oxidize fat, resulting in lipid accumulation and insulin resistance [2,9].”
BackgroundLatouche, C., Heywood, S. E., Henry, S. L., Ziemann, M., Lazarus, R. M., El‐Osta, A., Armitage, J. A., & Kingwell, B. A. (2013) · Journal of Nutrition · doi:10.3945/jn.113.186775 · Cited by 76
Cummings, B. P., Stanhope, K. L., Graham, J. L., Baskin, D. G., Griffen, S. C., Nilsson, C., Sams, A., Knudsen, L. B., Raun, K., & Havel, P. J. (2010) · Diabetes · doi:10.2337/db09-1564 · Cited by 72
“Reductions of circulating and ectopic TG content are likely to contribute to the improvement in insulin sensitivity, as deposition of TG in the liver impairs insulin signaling through the production of lipid metabolites that reduce insulin receptor substrate-2 tyrosine phosphorylation (37).”
BackgroundKoonen, D. P. Y., Sung, M. M. Y., Kao, C. K. C., Dolinsky, V. W., Koves, T. R., Ilkayeva, O., Jacobs, R. L., Vance, D. E., Light, P. E., Muoio, D. M., et al. (2010) · Diabetes · doi:10.2337/db09-1142 · Cited by 65
“That said, it is generally believed that skeletal muscle insulin resistance develops secondary to impaired mitochondrial fatty acid oxidation (4,5).”
BackgroundPhysiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes
Keller, M. P., & Attie, A. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104747 · Cited by 69
“Shulman and coworkers (100) have suggested that reduced mitochondrial respiratory capacity results in diminished fatty acid β-oxidation, resulting in an accumulation of lipid signaling molecules, specifically diacylglycerols, which activate several atypical protein kinase C isoforms that blunt insulin signaling throug…”
What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?
González-Franquesa, A., Burkart, A., ISGANAITIS, E. M., & Patti, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0763-1 · Cited by 77
Zhang, J., Wang, S., Zeng, Z., Qin, Y., Shen, Q., & Li, P. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103843 · Cited by 70
Mitochondrial function and endocrine diseases
Stark, R., & Roden, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01773.x · Cited by 75
Raddatz, K., Turner, N. A., Frangioudakis, G., Liao, B. M., Pedersen, D. J., Cantley, J., Wilks, D. L., Preston, E., Hegarty, B. D., Leitges, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2073-0 · Cited by 79
“The association of enhanced insulin action with increased lipid levels in liver argues against a role here for the accumulation of inhibitory lipid mediators in the generation of insulin resistance, which has been suggested to occur upon mitochondrial dysfunction and a reduction in fatty acid catabolism [ 25 ].”
BackgroundSharfi, H., & Eldar-Finkelman, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00534.2007 · Cited by 67
Papuc, C. P., GORAN, G. V., Predescu, N. C., Tudoreanu, L., & Ștefan, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1815644 · Cited by 77
Beals, J. W., Kayser, B. D., Smith, G. I., Schweitzer, G. G., Kirbach, K., Kearney, M. L., Yoshino, J., Rahman, G., Knight, R. D., Patterson, B. W., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00829-4 · Cited by 75
Yang, J., Yeh, H.-Y., Lin, K., & Wang, P. H. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.015 · Cited by 76
“Mitochondria have been implicated in the pathogenesis of Type 2 diabetes and metabolic syndrome [31,32].”
DeLany, J. P., Dubé, J. J., Standley, R. A., Distefano, G., Goodpaster, B. H., Stefanovic-Racic, M., Coen, P. M., & Toledo, F. G. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2512 · Cited by 66
“It has been postulated that reduced mitochondrial oxidative capacity might predispose to subtle impairments in lipid oxidation and thus exaggerate intramyocellular lipid accumulation and/or generation of insulin resistance-inducing lipid metabolites (29).”
BackgroundRivas, D. A., Lessard, S. J., Saito, M., Friedhuber, A. M., Koch, L. G., Britton, S. L., Yaspelkis, B. B., & Hawley, J. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00659.2010 · Cited by 75
“Reductions in the expression or activation of mitochondrial enzymes or proteins, like PGC1 , CPTI, or CS, are related to a decline in the oxidative capacity of skeletal muscle (4, 33, 43).”
BackgroundMouse KLF11 regulates hepatic lipid metabolism
Zhang, H., Chen, Q., Yang, M. H., Zhu, B., Cui, Y., Xue, Y., Gong, N., Cui, A., Wang, M., Shen, L., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.024 · Cited by 73
“However, the aberrant accumulation of fatty acids in the liver (fatty liver disease) may contribute to diabetes and other metabolic diseases [2].”
BackgroundMyricetin improves endurance capacity and mitochondrial density by activating SIRT1 and PGC-1α
Jung, H.-Y., Lee, D., Ryu, H. G., Choi, B.-H., Go, Y., Lee, N., Lee, D., Son, H. G., Jeon, J., Kim, S.-H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05303-2 · Cited by 64
Yap, K. H., Gan, S. Y., Candasamy, M., Tan, S. C., Md, S., Majeed, A. B. A., & Bhattamisra, S. K. (2020) · Biomolecules · doi:10.3390/biom10101360 · Cited by 71
Wu, J., Wu, J.-J., Yang, L., Wei, L., & Zou, D. (2012) · Endocrine · doi:10.1007/s12020-012-9826-5 · Cited by 69
Li, Y., Tran, V. H., Kota, B. P., Nammi, S., Duke, C. C., & Roufogalis, B. D. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12196 · Cited by 62
Denise Robertson, M. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005617 · Cited by 64
“The result is decreased glucose transport and phosphorylation, in addition to independent effects on insulin receptor signalling caused by accumulation of intramyocellular lipid metabolites, which impair insulin action despite prevailing hyperinsulinaemia (Morino et al. 2006; Fig.”
Ryu, M. J., Kim, S. J., Kim, Y. K., Choi, M. J., Tadi, S., Lee, M. H., Lee, S. E., Chung, H. K., Jung, S. B., Kim, H. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003356 · Cited by 68
“Mitochondrial dysfunction, characterized by reduced OXPHOS function in liver and skeletal muscle, is thought to be one of the underlying causes of insulin resistance and type 2 diabetes (for a review, see [39,40]).”
BackgroundCummings, B. P., Bettaieb, A., Graham, J. L., Kim, J., Ma, F., Shibata, N. M., Stanhope, K. L., Giulivi, C., Hansen, F. B., Jelsing, J., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010421 · Cited by 72
“Increases in nutrient-stimulated GLP-1 secretion might contribute to the improvement in insulin sensitivity by decreasing lipotoxicity, which is considered an important contributor to insulin resistance (Morino et al., 2006; Samuel et al., 2010).”
Nutritional approaches for managing obesity-associated metabolic diseases
Botchlett, R. E., Woo, S., Liu, M., Pei, Y., Guo, X., Li, H., & Wu, C. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0580 · Cited by 72
AKT signalling selectively regulates PINK1 mitophagy in SHSY5Y cells and human iPSC-derived neurons
Soutar, M. P. M., Kempthorne, L., Miyakawa, S., Annuario, E., Melandri, D., Harley, J., O’Sullivan, G. A., Wray, S., Hancock, D. C., Cookson, M. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26949-6 · Cited by 66
Evidence for altered insulin receptor signaling in Alzheimer's disease
Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 61
Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetes
Fealy, C. E., Mulya, A., Axelrod, C. L., & Kirwan, J. P. (2018) · Translational Research · doi:10.1016/j.trsl.2018.07.011 · Cited by 63
MECHANISMS IN ENDOCRINOLOGY: Pathogenesis of type 2 diabetes in South Asians
Bakker, L. E. H., Sleddering, M. A., Schoones, J. W., Meinders, A. E., & Jazet, I. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0307 · Cited by 62
Leem, J., & Koh, E. H. (2011) · Experimental Diabetes Research · doi:10.1155/2012/242984 · Cited by 67
“Increased serine phosphorylation of IRS-1 inhibits the tyrosine kinase activity of the insulin receptor on IRS1 and the activity of insulin-stimulated phosphatidylinositol 3-kinase (PI 3-kinase), resulting in decreased activity of insulin-stimulated protein kinase B (PKB, also known as AKT).”
BackgroundIqbal, S., & Naseem, I. (2014) · Nutrition · doi:10.1016/j.nut.2014.12.014 · Cited by 66
Mulyani, W. R. W., Sanjiwani, M. I. D., Sandra, S., Prabawa, I. P. Y., Lestari, A. A. W., Wihandani, D. M., Suastika, K., Saraswati, M. R., Bhargah, A., & Manuaba, I. B. P. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s232133 · Cited by 64
Anusree, S. S., Nisha, V. M., Priyanka, A., & Raghu, K. G. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.018 · Cited by 70
“Discussion Insulin resistance is a major contributor to the pathogenesis of diabetes, obesity and metabolic syndrome (Morino et al., 2006).”
BackgroundTransgenerational effects of fetal and neonatal exposure to nicotine
Holloway, A. C., Cuu, D. Q., Morrison, K. M., Gerstein, H. C., & Tarnopolsky, M. A. (2007) · Endocrine · doi:10.1007/s12020-007-0043-6 · Cited by 61
Vuong, A. M., Zhang, C., & Chen, A. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131642 · Cited by 65
Whytock, K. L., & Goodpaster, B. H. (2025) · Circulation Research · doi:10.1161/circresaha.125.325532 · Cited by 65
Romero-Ibarguengoitia, M. E., Vadillo‐Ortega, F., Caballero, A. E., Ibarra‐González, I., Herrera-Rosas, A., Serratos-Canales, M. F., León-Hernández, M., González-Chávez, A., Mummidi, S., Duggirala, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193138 · Cited by 61
Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches
Rector, R. S., Payne, R. M., & Ibdah, J. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.014 · Cited by 58
“AMPK is known to be activated by exercise and it has been shown that AMPK can activate mitochondrial biogenesis through MEF2- and CREB-mediated increased PGC-1α expression [81].”
BackgroundInsulin resistance and mitochondrial function in skeletal muscle
Dela, F., & Helge, J. W. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.019 · Cited by 66
Samjoo, I. A., Safdar, A., Hamadeh, M. J., Glover, A. W., Mocellin, N. J., Santana, J., Little, J. P., Steinberg, G. R., Raha, S., & Tarnopolsky, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066322 · Cited by 48
“obesity and T2D [8,21,22].”
Chung, N., Park, J., & Lim, K. (2017) · Physical Activity and Nutrition · doi:10.20463/jenb.2017.0020 · Cited by 61
Mitochondria-associated ER membranes in glucose homeostasis and insulin resistance
Townsend, L. K., Brunetta, H. S., & Mori, M. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00271.2020 · Cited by 59
Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz-Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J. R., & Sutherland, C. (2009) · Biochemical Journal · doi:10.1042/bj20082176 · Cited by 53
Lee, H., Ha, T. Y., Jung, C. H., Nirmala, F. S., Park, S., Huh, Y. H., & Ahn, J. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12794 · Cited by 59
“IR is an important risk factor for type 2 diabetes, coronary heart disease, and non-alcoholic fatty liver disease.(2) IR is also accompanied by reduced mitochondrial content of SKM.”
BackgroundImpaired glucose tolerance and metabolic syndrome in idiopathic neuropathy
Smith, A. G. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00390.x · Cited by 55
“Intracellular muscle and liver steatosis potently decrease insulin sensitivity in these tissues (Samocha-Bonet et al., 2010), in part by increasing protein kinase C-mediated phosphorylation of insulin receptor substrate-1 (Morino et al., 2006).”
BackgroundWang, L., Zeng, B., Zhang, X., Liao, Z., Gu, L., Liu, Z., Zhong, Q., Wei, H., & Fang, X. (2016) · Food & Function · doi:10.1039/c6fo01150k · Cited by 55
Gezginci-Oktayoğlu, S., Saçan, Ö., Bolkent, Ş., İpçi, Y., Kabasakal, L., Şener, G., & Yanardağ, R. (2013) · Acta Histochemica · doi:10.1016/j.acthis.2013.04.016 · Cited by 58
Redox regulation of insulin sensitivity due to enhanced fatty acid utilization in the mitochondria
Rindler, P. M., Crewe, C. L., Fernandes, J., Kinter, M., & Szweda, L. I. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00799.2012 · Cited by 54
Iron Overload Causes Oxidative Stress and Impaired Insulin Signaling in AML-12 Hepatocytes
Messner, D. J., Rhieu, B. H., & Kowdley, K. V. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2648-3 · Cited by 61
“They act in part through negative phospho-regulation of IRS proteins [45].”
Lamontagne, J., Pepin, E., Peyot, M.-L., Joly, E., Ruderman, N. B., Poitout, V., Madiraju, S. R. M., Nolan, C. J., & Prentki, M. (2009) · Endocrinology · doi:10.1210/en.2008-1557 · Cited by 55
Jani, S., Eira, D. D., Stefanovic, M., & Ceddia, R. B. (2022) · The Journal of Physiology · doi:10.1113/jp283552 · Cited by 68
“In its activated state, PKC inhibits tyrosine kinase activity of the insulin receptor (Morino et al., 2006), which then impairs all subsequent steps of the intracellular insulin signalling cascade causing insulin resistance.”
BackgroundChapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 58
“Control over insulin and IGF-1 signaling can be achieved in an auto regulatory manner, whereby downstream components inhibit upstream elements (negative-feedback control) (Gual et al., 2003; Morino et al., 2006).”
BackgroundInfluentialNehlin, J. O., Just, M., Rustan, A. C., & Gaster, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9336-5 · Cited by 65
“mitochondrial function appears to predispose elderly to insulin resistance and type 2 diabetes ( Morino et al. 2006; Petersen et al. 2003; Petersen and Shulman 2006).”
Background
Metadata
- Authors
- Morino, K., Petersen, K. F., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 55
- Issue
- Supplement_2
- Pages
- S9-S15
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2995546
- OpenAlex
- W2114416343
- Cited by
- 853
- References
- 91
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 29 · 2023: 35 · 2022: 26 · 2021: 28 · 2020: 48 · 2019: 38 · 2018: 42 · 2017: 39 · 2016: 60 · 2015: 34 · 2014: 53 · 2013: 54 · 2012: 63
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- U.S. Public Health Service (P30 DK45735, R01 DK-40936, R01 AG23686)
- National Institute on Aging (R01-AG-23686, R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, U24DK59635, P01 DK-063229, R01DK040936, U24DK059635, P30DK045735)
- National Center for Research Resources (M01RR000125, M01 RR-00125)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, mitochondrial dysfunction, insulin-stimulated glucose transport, muscle glycogen synthesis, intramyocellular lipid, fatty acyl-CoA, diacylglycerol, protein kinase C epsilon, IRS-1, insulin receptor substrate 2, hepatic insulin resistance, non-alcoholic fatty liver disease, mitochondrial density, magnetic resonance spectroscopy
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Liver, Mitochondria, Muscle, Muscles, Magnetic Resonance Spectroscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.